These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1310116)

  • 21. New trifluoromethyl quinolone derivatives: synthesis and investigation of antimicrobial properties.
    Panda SS; Jain SC
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3225-9. PubMed ID: 23611733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationships of 7-[3-(1-aminoalkyl)pyrrolidinyl]- and 7-[3-1-aminocycloalkyl)pyrrolidinyl]-quinolone antibacterials.
    Kimura Y; Atarashi S; Takahashi M; Hayakawa I
    Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1442-54. PubMed ID: 7923467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antibacterial activity of novel pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid derivatives carrying the 3-cyclopropylaminomethyl-4-substituted-1-pyrrolidinyl group as a C-10 substituent.
    Asahina Y; Takei M; Kimura T; Fukuda Y
    J Med Chem; 2008 Jun; 51(11):3238-49. PubMed ID: 18457383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antibacterial activity of new quinolones containing a 7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl] moiety. Gram-positive agents with excellent oral activity and low side-effect potential.
    Hagen SE; Domagala JM; Gracheck SJ; Sesnie JA; Stier MA; Suto MJ
    J Med Chem; 1994 Mar; 37(6):733-8. PubMed ID: 8145222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria.
    Emami S; Shafiee A; Foroumadi A
    Mini Rev Med Chem; 2006 Apr; 6(4):375-86. PubMed ID: 16613574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
    Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
    Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
    Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-methyl-3-methylaminopiperidin-1-yl)quinolones.
    Wan ZL; Chai Y; Liu ML; Guo HY; Sun LY
    Yao Xue Xue Bao; 2010 Jul; 45(7):860-8. PubMed ID: 20931783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and structure-activity relationship of 7-(alkyl, cycloalkyl, and vinyl)-1-cyclopropyl-6-fluoro-4-quinolone-3-carboxylic acids.
    Todo Y; Takagi H; Iino F; Fukuoka Y; Ikeda Y; Tanaka K; Saikawa I; Narita H
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2049-54. PubMed ID: 7805129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).
    Hayashi K; Takahata M; Kawamura Y; Todo Y
    Arzneimittelforschung; 2002; 52(12):903-13. PubMed ID: 12572531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoronaphthyridines as antibacterial agents. 6. Synthesis and structure-activity relationships of new chiral 7-(1-, 3-, 4-, and 6-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)naphthyridine analogues of 7-[(1R,4R)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-1-(1,1-dimethylethyl)-6-fluoro-1,4-dihy dro-4-oxo-1,8-naphthyridine-3-carboxylic acid. Influence of the configuration on blood pressure in dogs. A quinolone-class effect.
    Remuzon P; Bouzard D; Guiol C; Jacquet JP
    J Med Chem; 1992 Jul; 35(15):2898-909. PubMed ID: 1322990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synthesis and antibacterial activities of quinolones containing five- and six-membered heterocyclic substituents at the 7-position.
    Cooper CS; Klock PL; Chu DT; Fernandes PB
    J Med Chem; 1990 Apr; 33(4):1246-52. PubMed ID: 2319566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
    Kiely JS; Hutt MP; Culbertson TP; Bucsh RA; Worth DF; Lesheski LE; Gogliotti RD; Sesnie JC; Solomon M; Mich TF
    J Med Chem; 1991 Feb; 34(2):656-63. PubMed ID: 1995890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent non-6-fluoro-substituted quinolone antibacterials: synthesis and biological activity.
    Ledoussal B; Bouzard D; Coroneos E
    J Med Chem; 1992 Jan; 35(1):198-200. PubMed ID: 1732530
    [No Abstract]   [Full Text] [Related]  

  • 35. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
    Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
    Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group.
    Kuramoto Y; Ohshita Y; Yoshida J; Yazaki A; Shiro M; Koike T
    J Med Chem; 2003 May; 46(10):1905-17. PubMed ID: 12723953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
    McGuirk PR; Jefson MR; Mann DD; Elliott NC; Chang P; Cisek EP; Cornell CP; Gootz TD; Haskell SL; Hindahl MS
    J Med Chem; 1992 Feb; 35(4):611-20. PubMed ID: 1311762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro Antibacterial Activity of 7-Substituted-6-Fluoroquinolone and 7-Substituted-6,8-Difluoroquinolone Derivatives.
    Leyva-Ramos S; de Loera D; Cardoso-Ortiz J
    Chemotherapy; 2017; 62(3):194-198. PubMed ID: 28334702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro antibacterial activity of quinolone/naphthyridone derivatives containing 3-alkoxyimino-4-(methyl)aminopiperidine scaffolds.
    Lv K; Wu J; Wang J; Liu M; Wei Z; Cao J; Sun Y; Guo H
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1754-9. PubMed ID: 23402878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and in vitro and in vivo evaluation of quinolones with selective activity against gram-positive organisms.
    Cooper CS; Klock PL; Chu DT; Hardy DJ; Swanson RN; Plattner JJ
    J Med Chem; 1992 Apr; 35(8):1392-8. PubMed ID: 1573632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.